Table 2.
Correlations between aerobic fitness and markers of CVD risk. Data presented are the Pearson’s correlation coefficient (r), probability (p) and sample size (n).
Peak oxygen uptake
(mL·kg
-0.61.
min
-1
)
Peak oxygen uptake
(mL·FFM
-1.
min
-1
)
Whole group
Boys
Girls
Whole group
Boys
Girls
BMI (kg·m
-2
)
r=-0.12; p=0.25
n=96
r=-0.16; p=0.25
n=53
r=-0.08; p=0.62
n=43
r=-0.11; p=0.34
n=86
r=-0.03; p=0.82
n=50
r=-0.17; p=0.33
n=36
TBF%
r=-0.34; p=0.001
n=86
r=-0.19; p=0.19
n=50
r=-0.34; p=0.044
n=36
r=0.04; p=0.75
n=86
r=0.23; p=0.17
n=50
r=-0.04; p=0.84
n=36
VAT (cm
3
)
r=-0.07; p=0.56
n=86
r=-0.25; p=0.09
n=49
r=0.06; p=0.72
n=37
r=-0.04; p=0.73
n=78
r=-0.06; p=0.69
n=46
r=0.03; p=0.87
n=32
Total cholesterol (mmol.L
-1
)
r=-0.11; p=0.30
n=79
r=-0.09; p=0.54
n=49
r=-0.10; p=0.60
n=30
r=0.06; p=0.61
n=71
r=0.05; p=0.75
n=46
r=0.02; p=0.93
n=25
HDL-C (mmol.L
-1
)
r=-0.05; p=0.67
n=78
r=-0.11; p=0.44
n=49
r=-0.07; p=0.74
n=29
r=0.10; p=0.43
n=70
r=0.05; p=0.74
n=46
r=0.15; p=0.48
n=24
LDL-C (mmol.L
-1
)
r=-0.06; p=0.63
n=78
r=-0.05; p=0.75
n=49
r=-0.08; p=0.67
n=29
r<0.01; p=0.99
n=70
r=-0.01; p=0.95
n=46
r=-0.03; p=0.91
n=24
TG (mmol.L
-1
)
r=0.02; p=0.88
n=79
r=0.15; p=0.31
n=49
r=-0.07; p=0.73
n=30
r=0.04; p=0.75
n=71
r=0.10; p=0.50
n=46
r=-0.04; p=0.86
n=25
Glucose (mmol.L
-1
)
r=-0.10; p=0.39
n=80
r=-0.09; p=0.55
n=49
r=-0.10; p=0.58
n=31
r=-0.14; p=0.25
n=72
r=-0.12; p=0.42
n=46
r=-0.14; p=0.49
n=26
Specific insulin
(pmol.L
-1
)
r=0.07; p=0.55
n=77
r=0.12; p=0.44
n=46
r=-0.17; p=0.36
n=31
r=0.10; p=0.44
n=69
r=0.34; p=0.028
n=43
r=-0.21; p=0.30
n=26
β-cell function (%)
r=-0.05; p=0.69
n=77
r=0.13; p=0.39
n=46
r=-0.12; p=0.52
n=31
r=0.16; p=0.20
n=69
r=0.38; p=0.011
n=43
r=-0.12; p=0.55
n=26
HOMA-IS (%)
r=0.07; p=0.52
n=77
r=-0.13; p=0.40
n=46
r=0.19; p=0.30
n=31
r=0.09; p=0.47
n=69
r=-0.32; p=0.036
n=43
r=0.21; p=0.31
n=26
HOMA-IR
r=-0.08; p=0.50
n=77
r=0.10; p=0.50
n=46
r=-0.17; p=0.35
n=31
r=0.08; p=0.52
n=69
r=0.31; p=0.042
n=43
r=-0.21; p=0.31
n=26